J&J rounds out the year with twin buy­outs, gain­ing con­trol of de­liv­ery and sur­gi­cal ro­bot­ics tech

J&J is scoop­ing up one of Bris­tol-My­ers-Squibb’s biotech part­ners spe­cial­ized in blad­der bi­ol­o­gy, with a par­tic­u­lar­ly keen in­ter­est in a tech­nol­o­gy that re­leas­es can­cer drugs …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER